Varian Inks Licensing Deal with Fraunhofer for Novel Multi-Criteria Optimization (MCO) Tool for Radiotherapy Treatment Planning

By: via Benzinga
Varian Medical Systems (NYSE: VAR) today announced that it will be adding a new tool to its radiotherapy treatment planning software ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.